These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1597263

  • 21. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
    Vorhees CV, Acuff-Smith KD, Weisenburger WP, Minck DR, Berry JS, Setchell KD, Nau H.
    Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V, Wlodarczyk B, Giavini E, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid.
    Tiboni GM, Chiarelli F, Verrotti A.
    In Vivo; 2013 Mar; 27(4):513-8. PubMed ID: 23812222
    [Abstract] [Full Text] [Related]

  • 26. Nonspecific stimulation of the maternal immune system. I. Effects On teratogen-induced fetal malformations.
    Holladay SD, Sharova L, Smith BJ, Gogal RM, Ward DL, Blaylock BL.
    Teratology; 2000 Dec; 62(6):413-9. PubMed ID: 11091363
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
    Hsieh CL, Wang HE, Tsai WJ, Peng CC, Peng RY.
    Toxicology; 2012 Jan 27; 291(1-3):32-42. PubMed ID: 22051200
    [Abstract] [Full Text] [Related]

  • 31. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Jan 27; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A rat model of valproate teratogenicity from chronic oral treatment during pregnancy.
    Jazayeri D, Braine E, McDonald S, Dworkin S, Powell KL, Griggs K, Vajda FJE, O'Brien TJ, Jones NC.
    Epilepsia; 2020 Jun 27; 61(6):1291-1300. PubMed ID: 32415786
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice.
    Hall JL, Harris MJ, Juriloff DM.
    Teratology; 1997 May 27; 55(5):306-13. PubMed ID: 9261924
    [Abstract] [Full Text] [Related]

  • 39. Valproic acid-induced neural tube defects.
    Nau H.
    Ciba Found Symp; 1994 May 27; 181():144-52; discussion 152-60. PubMed ID: 8005022
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.